Adverse Effects of Imatinib Mesylat: 5-Year Follow-Up of 55 Patients With Chronic Myeloid Leukemia in Dakar (S�n�gal)

Open Journal of Hematology - Pakistan
doi 10.13055/ojhmt_6_1_4.150509
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ross Science Publishers

Related search

Nilotinib vs Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: ENESTnd 3-Year Follow-Up

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

2012English

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

Imatinib and Plasmacytoid Dendritic Cell Function in Patients With Chronic Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Gene Expression Signature of Primary Imatinib-Resistant Chronic Myeloid Leukemia Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Long-Term Follow-Up of Patients With Chronic Myeloid Leukemia Having Received Autologous Stem Cell Transplantation.

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Treatment of Chronic Myeloid Leukemia With Generic Imatinib in Patients From Northeastern Part of India

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2019English

In Vitro Effects of Imatinib on CD34+ Cells of Patients With Chronic Myeloid Leukemia in the Megakaryocytic Crisis Phase

Oncology Letters
Cancer ResearchOncology
2014English

Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy